Dr. Gregory Golembeski, MD
- Medicare patients, 2024
- 22
- Part D claims, 2024
- 150
- MIPS score, 2024
- 97
- Hospital affiliations
- 1
- Industry payments
- $85
- Practice address
- 4641 Roosevelt Boulevard, Philadelphia, PA 19124
- Practice phone
- Call (215) 831-4600
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Golembeski's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Gregory Golembeski is a psychiatrist in Philadelphia, Pennsylvania
Dr. Golembeski practices at Friends Hospital in Philadelphia, Pennsylvania, part of Universal Health Services.
Dr. Golembeski's NPI, 1457090011, was assigned on June 1, 2022. Dr. Golembeski holds Pennsylvania license MD485874.
- NPI
- 1457090011NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3173901840
- NPI enumeration date
- June 1, 2022
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (215) 831-4600
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 30
- Medical school graduation
- 2022
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Gregory Golembeski practices at Friends Hospital in Philadelphia, Pennsylvania
Dr. Golembeski's primary practice is Friends Hospital, at 4641 Roosevelt Boulevard, Philadelphia, PA 19124 in Philadelphia County. The practice phone is (215) 831-4600.
- Friends Hospital4641 Roosevelt Boulevard, Philadelphia, PA 19124 · Philadelphia CountyPhone(215) 831-4600
Source: Dmand AI Affiliation Data
Dr. Gregory Golembeski is affiliated with 2 sites of care and 2 medical groups
Dr. Golembeski's primary practice is Friends Hospital in Philadelphia, Pennsylvania, part of Universal Health Services. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Golembeski to 1 more group practice or clinic and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Gregory Golembeski's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Golembeski practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Friends Hospital | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Universal Health Services and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Gregory Golembeski is one of 1,873 psychiatrists in Pennsylvania
Psychiatry is Dr. Golembeski's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Golembeski is licensed in Pennsylvania.
Specialties and state licenses
- Psychiatry, PennsylvaniaPrimary
Psychiatrists near Dr. Golembeski
Counts of psychiatrists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Gregory Golembeski treated 22 Medicare patients in 2024, average age 52
CMS counts 22 Medicare patients who saw Dr. Golembeski in 2024. 75% of them have mood disorders, and 73% have schizophrenia and other psychoses. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Golembeski's median patient age at 36, with 44% women.
Chronic conditions among Dr. Golembeski's Medicare patients, 2024
- Mood disorders75%
- Schizophrenia and other psychoses73%
- Depression68%
- Tobacco use68%
- Anxiety64%
- Bipolar disorder64%
- High cholesterol64%
- High blood pressure59%
Share of Medicare patients with each condition. A patient can have several.
Dr. Golembeski's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 36
Patient panel by sex, all payers
- Women44%
- Men56%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Gregory Golembeski wrote 150 Medicare Part D claims in 2024
In 2024, Dr. Golembeski wrote 150 Medicare Part D claims for 27 patients. 99% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $406 in total drug cost.
Dr. Golembeski's Part D claims by kind of drug, 2024
- Generic149 claims99%
- Brand-name and other1 claims1%
Dr. Golembeski's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Gregory Golembeski scored 97 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Golembeski for performance year 2024, reported through an alternative payment model (APM). Dr. Golembeski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Golembeski's MIPS scores, performance year 2024
- 97of 100Final score
- 82.3of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Gregory Golembeski received $85 in industry payments from 2022 to 2025
CMS Open Payments shows 4 general payments to Dr. Golembeski from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $44.
General payments to Dr. Golembeski by program year, 2022 to 2025
Companies that paid Dr. Golembeski the most, 2022 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Gregory Golembeski's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Gregory Golembeski
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Gregory Golembeski's NPI number?
Dr. Gregory Golembeski's NPI number is 1457090011. It was assigned on June 1, 2022, and it is active in the NPI Registry.
What kind of doctor is Dr. Gregory Golembeski?
Dr. Gregory Golembeski is a psychiatrist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Psychiatry Physician (taxonomy code 2084P0800X).
Where does Dr. Gregory Golembeski practice?
Dr. Golembeski practices at 4641 Roosevelt Boulevard, Philadelphia, PA 19124. Dr. Golembeski's primary practice is Friends Hospital in Philadelphia, Pennsylvania, part of Universal Health Services. Dmand AI also links Dr. Golembeski to 1 group practice or clinic and 1 medical group.
What is Dr. Gregory Golembeski's office phone number?
The practice phone on file for Dr. Golembeski is (215) 831-4600.
What is Dr. Gregory Golembeski's medical license number?
Dr. Golembeski holds Pennsylvania license MD485874.
Which hospitals is Dr. Gregory Golembeski affiliated with?
Dr. Golembeski practices at Friends Hospital in Philadelphia, Pennsylvania.
What medical group is Dr. Gregory Golembeski part of?
Dr. Golembeski is linked to St. Luke's South Mountain Family Practice. Dmand AI links Dr. Golembeski to 1 more medical group.
Does Dr. Gregory Golembeski accept Medicare?
Yes. CMS lists Dr. Golembeski as accepting Medicare assignment.
What is Dr. Gregory Golembeski's MIPS score?
Dr. Golembeski's MIPS final score for performance year 2024 is 97 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Gregory Golembeski see?
CMS counts 22 Medicare patients who saw Dr. Golembeski in 2024, with an average age of 52.
Show 3 more questionsShow fewer questions
What drugs does Dr. Gregory Golembeski prescribe most?
In 2024 Medicare Part D data, Dr. Golembeski's most prescribed drugs by claims were Gabapentin, Sertraline HCl and Fluoxetine HCl.
Has Dr. Gregory Golembeski received payments from drug or device companies?
CMS Open Payments shows $85 in general payments to Dr. Golembeski from 3 companies from 2022 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Gregory Golembeski been practicing?
Dr. Golembeski graduated from medical school in 2022, 4 years ago.
Selling to psychiatry practices?
See psychiatrists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card